Education
About Us
Working with TipRanks
Follow Us
Genomma Lab Internacional SAB de CV Class B (DE:GEKA)
:GEKA
RESEARCH TOOLSreports
Total Valuation
Genomma Lab Internacional SAB de CV has a market cap or net worth of €1.02B. The enterprise value is ―.
Market Cap€1.02B
Enterprise Value―
Share Statistics
Genomma Lab Internacional SAB de CV has 1,000,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,000,000,000
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Genomma Lab Internacional SAB de CV’s return on equity (ROE) is 0.18 and return on invested capital (ROIC) is 16.99%.
Return on Equity (ROE)0.18
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)16.99%
Return on Capital Employed (ROCE)0.23
Revenue Per Employee11.59M
Profits Per Employee1.33M
Employee Count1,605
Asset Turnover0.77
Inventory Turnover3.07
Valuation Ratios
The current PE Ratio of Genomma Lab Internacional SAB de CV is 11.72. Genomma Lab Internacional SAB de CV’s PEG ratio is <0.01.
PE Ratio11.72
PS Ratio0.00
PB Ratio0.12
Price to Fair Value2.16
Price to FCF0.56
Price to Operating Cash Flow0.49
PEG Ratio<0.01
Income Statement
In the last 12 months, Genomma Lab Internacional SAB de CV had revenue of 18.61B and earned 2.14B in profits. Earnings per share was 2.26.
Revenue18.61B
Gross Profit11.93B
Operating Income3.98B
Pretax Income2.89B
Net Income2.14B
EBITDA4.14B
Earnings Per Share (EPS)2.26
Cash Flow
In the last 12 months, operating cash flow was 2.73B and capital expenditures -134.24M, giving a free cash flow of 2.56B billion.
Operating Cash Flow2.73B
Free Cash Flow2.56B
Free Cash Flow per Share2.56
Dividends & Yields
Genomma Lab Internacional SAB de CV pays an annual dividend of €0.034, resulting in a dividend yield of 4.43%
Dividend Per Share€0.034
Dividend Yield4.43%
Payout Ratio30.89%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.52
52-Week Price Change7.88%
50-Day Moving Average1.05
200-Day Moving Average1.08
Relative Strength Index (RSI)39.65
Average Volume (3m)0.00
Important Dates
Genomma Lab Internacional SAB de CV upcoming earnings date is Jul 23, 2025, TBA Not Confirmed.
Last Earnings DateApr 30, 2025
Next Earnings DateJul 23, 2025
Ex-Dividend DateMar 13, 2025
Financial Position
Genomma Lab Internacional SAB de CV as a current ratio of 1.84, with Debt / Equity ratio of 43.71%
Current Ratio1.84
Quick Ratio1.51
Debt to Market Cap0.20
Net Debt to EBITDA0.65
Interest Coverage Ratio4.49
Taxes
In the past 12 months, Genomma Lab Internacional SAB de CV has paid 753.78M in taxes.
Income Tax753.78M
Effective Tax Rate0.26
Enterprise Valuation
Genomma Lab Internacional SAB de CV EV to EBITDA ratio is 6.70, with an EV/FCF ratio of 9.93.
EV to Sales1.49
EV to EBITDA6.70
EV to Free Cash Flow9.93
EV to Operating Cash Flow9.18
Balance Sheet
Genomma Lab Internacional SAB de CV has €2.38B in cash and marketable securities with $5.06B in debt, giving a net cash position of €2.69B billion.
Cash & Marketable Securities€2.38B
Total Debt$5.06B
Net Cash€2.69B
Net Cash Per Share€2.69
Tangible Book Value Per Share€5.98
Margins
Gross margin is 63.72%, with operating margin of 21.40%, and net profit margin of 11.49%.
Gross Margin63.72%
Operating Margin21.40%
Pretax Margin15.54%
Net Profit Margin11.49%
EBITDA Margin22.24%
EBIT Margin20.31%
Analyst Forecast
The average price target for Genomma Lab Internacional SAB de CV is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―